Therapeutic drug monitoring for isoniazid and rifampicin exposure

被引：1
|
作者：
Peloquin, C. A. [1 ]
机构：
[1] Univ Florida, Coll Pharm, POB 100486,1600 SW Archer Rd, Gainesville, FL 32610 USA
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2024年 / 28卷 / 03期
关键词：
isoniazid; rifampin; drug exposure; therapeutic drug monitoring;
D O I：
10.5588/ijtld.23.0495
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [1] Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid
    Ray, J
    Gardiner, I
    Marriott, D
    INTERNAL MEDICINE JOURNAL, 2003, 33 (5-6) : 229 - 234
  • [2] Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
    Chiara Tersigni
    Giulia Boiardi
    Lorenzo Tofani
    Elisabetta Venturini
    Carlotta Montagnani
    Barbara Bortone
    Leila Bianchi
    Elena Chiappini
    Maria Iris Cassetta
    Stefania Fallani
    Andrea Novelli
    Luisa Galli
    BMC Infectious Diseases, 21
  • [3] Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
    Tersigni, Chiara
    Boiardi, Giulia
    Tofani, Lorenzo
    Venturini, Elisabetta
    Montagnani, Carlotta
    Bortone, Barbara
    Bianchi, Leila
    Chiappini, Elena
    Cassetta, Maria Iris
    Fallani, Stefania
    Novelli, Andrea
    Galli, Luisa
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [4] Therapeutic Monitoring of Isoniazid, Pyrazinamide and Rifampicin in Tuberculosis Patients Using LC
    S. Unsalan
    M. Sancar
    B. Bekce
    P. M. Clark
    T. Karagoz
    F. V. Izzettin
    S. Rollas
    Chromatographia, 2005, 61 : 595 - 598
  • [5] Therapeutic monitoring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC
    Unsalan, S
    Sancar, M
    Bekce, B
    Clark, PM
    Karagoz, T
    Izzettin, FV
    Rollas, S
    CHROMATOGRAPHIA, 2005, 61 (11-12) : 595 - 598
  • [6] Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis
    Alshaikheid, Mohammed
    Ben Romdhane, Haifa
    Ben Fredj, Nadia
    Ben Fadhel, Najah
    Aouam, Abir
    Chadli, Zohra
    Boughattas, Naceur
    Chaabane, Amel
    Aouam, Karim
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (07): : 972 - 978
  • [7] A Simple and Sensitive UPLC-UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring
    Jiang, Zhimei
    Huang, Liang
    Zhang, Lingli
    Yu, Qin
    Lin, Yunzhu
    Fei, Haotian
    Shen, Hongxin
    Huang, Hong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [8] Amiodarone Rifampicin Drug-Drug Interaction Management With Therapeutic Drug Monitoring
    Munnink, Thijs H. Oude
    Demmer, Anna
    Slenter, Roel H. J.
    Movig, Kris L. L.
    THERAPEUTIC DRUG MONITORING, 2018, 40 (02) : 159 - 161
  • [9] Therapeutic monitoring of isoniazid, rifampicin, ethambutol and pyrazinamide serum levels in the treatment of active pulmonary tuberculosis and determinants of their serum concentrations
    Kayhan, Servet
    Akgunes, Alper
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (17): : 2035 - 2041
  • [10] Spirulina maxima Protects Liver From Isoniazid and Rifampicin Drug Toxicity
    Jatav, Santosh Kumar
    Kulshrestha, Archana
    Zacharia, Anish
    Singh, Nita
    Tejovathi, G.
    Bisen, P. S.
    Prasad, G. B. K. S.
    JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2014, 19 (03): : 189 - 194
12345